Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer.

Clancy J. Clark, Janani S. Arun, Rondell Graham, Lizhi Zhang, Michael Farnell, Kaye M. Reid-Lombardo

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Anaplastic pancreatic cancer (APC) is a rare undifferentiated variant of pancreatic ductal adenocarcinoma with poor overall survival (OS). The aim of this study was to evaluate the clinical outcomes of APC compared with differentiated pancreatic ductal adenocarcinoma. We conducted a retrospective review of all patients treated at the Mayo Clinic with pathologically confirmed APC from 1987 to 2011. After matching with control subjects with pancreatic ductal adenocarcinoma, OS was evaluated using Kaplan-Meier estimates and log-rank test. Sixteen patients were identified with APC (56.3% male, median age 57 years). Ten patients underwent exploration of whom eight underwent pancreatectomy. Perioperative morbidity was 60 per cent with no mortality. The median OS was 12.8 months. However, patients with APC who underwent resection had longer OS compared with those who were not resected, 34.1 versus 3.3 months (P = 0.001). After matching age, sex, tumor stage, and year of operation, the median OS was similar between patients with APC and those with ductal adenocarcinoma treated with pancreatic resection, 44.1 versus 39.9 months, (P = 0.763). Overall survival for APC is poor; however, when resected, survival is similar to differentiated pancreatic ductal adenocarcinoma.

Original languageEnglish (US)
Title of host publicationThe American surgeon
Pages117-123
Number of pages7
Volume80
Edition2
StatePublished - 2014

Fingerprint

Pancreatic Neoplasms
Survival
Adenocarcinoma
Pancreatectomy
Kaplan-Meier Estimate
Morbidity
Mortality
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clark, C. J., Arun, J. S., Graham, R., Zhang, L., Farnell, M., & Reid-Lombardo, K. M. (2014). Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. In The American surgeon (2 ed., Vol. 80, pp. 117-123)

Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. / Clark, Clancy J.; Arun, Janani S.; Graham, Rondell; Zhang, Lizhi; Farnell, Michael; Reid-Lombardo, Kaye M.

The American surgeon. Vol. 80 2. ed. 2014. p. 117-123.

Research output: Chapter in Book/Report/Conference proceedingChapter

Clark, CJ, Arun, JS, Graham, R, Zhang, L, Farnell, M & Reid-Lombardo, KM 2014, Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. in The American surgeon. 2 edn, vol. 80, pp. 117-123.
Clark CJ, Arun JS, Graham R, Zhang L, Farnell M, Reid-Lombardo KM. Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. In The American surgeon. 2 ed. Vol. 80. 2014. p. 117-123
Clark, Clancy J. ; Arun, Janani S. ; Graham, Rondell ; Zhang, Lizhi ; Farnell, Michael ; Reid-Lombardo, Kaye M. / Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. The American surgeon. Vol. 80 2. ed. 2014. pp. 117-123
@inbook{f41dcc464f034fcaa4e10eac3cb1ccf7,
title = "Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer.",
abstract = "Anaplastic pancreatic cancer (APC) is a rare undifferentiated variant of pancreatic ductal adenocarcinoma with poor overall survival (OS). The aim of this study was to evaluate the clinical outcomes of APC compared with differentiated pancreatic ductal adenocarcinoma. We conducted a retrospective review of all patients treated at the Mayo Clinic with pathologically confirmed APC from 1987 to 2011. After matching with control subjects with pancreatic ductal adenocarcinoma, OS was evaluated using Kaplan-Meier estimates and log-rank test. Sixteen patients were identified with APC (56.3{\%} male, median age 57 years). Ten patients underwent exploration of whom eight underwent pancreatectomy. Perioperative morbidity was 60 per cent with no mortality. The median OS was 12.8 months. However, patients with APC who underwent resection had longer OS compared with those who were not resected, 34.1 versus 3.3 months (P = 0.001). After matching age, sex, tumor stage, and year of operation, the median OS was similar between patients with APC and those with ductal adenocarcinoma treated with pancreatic resection, 44.1 versus 39.9 months, (P = 0.763). Overall survival for APC is poor; however, when resected, survival is similar to differentiated pancreatic ductal adenocarcinoma.",
author = "Clark, {Clancy J.} and Arun, {Janani S.} and Rondell Graham and Lizhi Zhang and Michael Farnell and Reid-Lombardo, {Kaye M.}",
year = "2014",
language = "English (US)",
volume = "80",
pages = "117--123",
booktitle = "The American surgeon",
edition = "2",

}

TY - CHAP

T1 - Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer.

AU - Clark, Clancy J.

AU - Arun, Janani S.

AU - Graham, Rondell

AU - Zhang, Lizhi

AU - Farnell, Michael

AU - Reid-Lombardo, Kaye M.

PY - 2014

Y1 - 2014

N2 - Anaplastic pancreatic cancer (APC) is a rare undifferentiated variant of pancreatic ductal adenocarcinoma with poor overall survival (OS). The aim of this study was to evaluate the clinical outcomes of APC compared with differentiated pancreatic ductal adenocarcinoma. We conducted a retrospective review of all patients treated at the Mayo Clinic with pathologically confirmed APC from 1987 to 2011. After matching with control subjects with pancreatic ductal adenocarcinoma, OS was evaluated using Kaplan-Meier estimates and log-rank test. Sixteen patients were identified with APC (56.3% male, median age 57 years). Ten patients underwent exploration of whom eight underwent pancreatectomy. Perioperative morbidity was 60 per cent with no mortality. The median OS was 12.8 months. However, patients with APC who underwent resection had longer OS compared with those who were not resected, 34.1 versus 3.3 months (P = 0.001). After matching age, sex, tumor stage, and year of operation, the median OS was similar between patients with APC and those with ductal adenocarcinoma treated with pancreatic resection, 44.1 versus 39.9 months, (P = 0.763). Overall survival for APC is poor; however, when resected, survival is similar to differentiated pancreatic ductal adenocarcinoma.

AB - Anaplastic pancreatic cancer (APC) is a rare undifferentiated variant of pancreatic ductal adenocarcinoma with poor overall survival (OS). The aim of this study was to evaluate the clinical outcomes of APC compared with differentiated pancreatic ductal adenocarcinoma. We conducted a retrospective review of all patients treated at the Mayo Clinic with pathologically confirmed APC from 1987 to 2011. After matching with control subjects with pancreatic ductal adenocarcinoma, OS was evaluated using Kaplan-Meier estimates and log-rank test. Sixteen patients were identified with APC (56.3% male, median age 57 years). Ten patients underwent exploration of whom eight underwent pancreatectomy. Perioperative morbidity was 60 per cent with no mortality. The median OS was 12.8 months. However, patients with APC who underwent resection had longer OS compared with those who were not resected, 34.1 versus 3.3 months (P = 0.001). After matching age, sex, tumor stage, and year of operation, the median OS was similar between patients with APC and those with ductal adenocarcinoma treated with pancreatic resection, 44.1 versus 39.9 months, (P = 0.763). Overall survival for APC is poor; however, when resected, survival is similar to differentiated pancreatic ductal adenocarcinoma.

UR - http://www.scopus.com/inward/record.url?scp=84897571010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897571010&partnerID=8YFLogxK

M3 - Chapter

C2 - 24480210

AN - SCOPUS:84897571010

VL - 80

SP - 117

EP - 123

BT - The American surgeon

ER -